Cargando…

Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab

Detalles Bibliográficos
Autores principales:	Edmonds, Nicole, Noland, Margaret, Flowers, R. Hal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649573/ https://www.ncbi.nlm.nih.gov/pubmed/34926750 http://dx.doi.org/10.1016/j.jdcr.2021.10.030

Ejemplares similares

Dupilumab for cancer-associated refractory pruritus
por: Talmon, Aviv, et al.
Publicado: (2023)

A successful case of dupilumab treatment for severe uremic pruritus
por: Silverberg, Jonathan I., et al.
Publicado: (2019)

Dupilumab Failure in Treating Dermatomyositis-Associated Pruritus
por: O'Brien, Margaret A, et al.
Publicado: (2022)

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation
por: Alipour Tehrany, Yassaman, et al.
Publicado: (2020)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Recalcitrant anal and genital pruritus treated with dupilumab()()()()
por: Yang, E.J., et al.
Publicado: (2018)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
por: Buttgereit, Thomas, et al.
Publicado: (2021)

Chronic Pruritus Responding to Dupilumab—A Case Series
por: Zhai, Lisa L., et al.
Publicado: (2019)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
por: Shahriari, Neda, et al.
Publicado: (2023)

Dupilumab for the treatment of severe photodermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Pruritus after discontinuation of cetirizine
por: Chung, Amy H., et al.
Publicado: (2019)

Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study
por: Inaba, Yutaka, et al.
Publicado: (2022)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023)

Unbearable Pruritus After Withdrawal of (Levo)cetirizine
por: Ekhart, Corine, et al.
Publicado: (2016)

Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritus
por: Robinson, Warner, et al.
Publicado: (2023)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
por: Jiang, Christina, et al.
Publicado: (2023)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019)

Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
por: Luo, Nana, et al.
Publicado: (2022)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

Review of dupilumab-associated inflammatory arthritis: An approach to clinical analysis and management
por: Jay, Ryan, et al.
Publicado: (2022)

Upadacitinib as a treatment for chronic pruritus secondary to polycythemia vera after failure with dupilumab
por: Wachuku, Christopher I., et al.
Publicado: (2023)

Dupilumab in HIV-positive patients: A case series report of 4 patients
por: Alawadhi, Ameen, et al.
Publicado: (2020)

The use of montelukast for pruritus in neurofibromatosis 1
por: Edmonds, Nicole L., et al.
Publicado: (2022)

Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
por: Arnold, Kathryn A., et al.
Publicado: (2018)

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series
por: Chen, Jiaoquan, et al.
Publicado: (2023)

A persistent dermal hypersensitivity reaction associated with Helicobacter pylori infection
por: Dautriche, Cula N., et al.
Publicado: (2020)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real‐life study
por: Mastorino, Luca, et al.
Publicado: (2021)

Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab
por: Beck, Tyler C., et al.
Publicado: (2023)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
por: Ceryn, Justyna, et al.
Publicado: (2021)

IL-31 is crucial for induction of pruritus, but not inflammation, in contact hypersensitivity
por: Takamori, Ayako, et al.
Publicado: (2018)

Trigeminal neuralgia: successful antiepileptic drug combination therapy in three refractory cases
por: Prisco, Lara, et al.
Publicado: (2011)

Successful Treatment of Refractory Massive Pulmonary Embolism with Repeated Administration of Systemic Thrombolysis
por: Poor, Armeen D., et al.
Publicado: (2018)

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
por: Zhang, Honghong, et al.
Publicado: (2017)

Successful treatment of trichothiodystrophy with dupilumab
por: Gruber, R., et al.
Publicado: (2021)

Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy
por: Rana, Jasmine, et al.
Publicado: (2021)

Brachioradial pruritus treated with computed tomography-guided cervical nerve root block: A case series
por: Weinberg, Brent D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g3ts9j521c592nkqbdpjnbl2st